Hyperspectral imaging of the early embryo: can it detect chromosome abnormalities and predict IVF success?

Tiffany C. Y. Tan; Carl Campugan; Saabah B. Mahbub; Jared M. Campbell; Abbas Habibalahi; Sanam Mustafa; Ewa M. Goldys; Jeremy G. Thompson; Kylie R. Dunning

doi:10.1117/12.2541282

30 December 2019 Hyperspectral imaging of the early embryo: can it detect chromosome abnormalities and predict IVF success?

Tiffany C. Y. Tan, Carl Campugan, Saabah B. Mahbub, Jared M. Campbell, Abbas Habibalahi, Sanam Mustafa, Ewa M. Goldys, Jeremy G. Thompson, Kylie R. Dunning

Author Affiliations +

Proceedings Volume 11202, Biophotonics Australasia 2019; 112020M (2019) https://doi.org/10.1117/12.2541282
Event: ANZCOP, 2019, Melbourne, Australia

Abstract

Despite its wide-spread use, the success rate of assisted reproductive technologies including in vitro fertilization is less than 20%. Most human embryos are mosaic for chromosome abnormalities: containing cells that are euploid (normal) and aneuploid (incorrect number of chromosomes). Currently, a cell biopsy is used in IVF clinics to diagnose aneuploidy in the embryo but this does not provide a diagnosis of how many cells are aneuploid in the entire embryo. Hence, the development of a non-invasive tool to determine the proportion of aneuploid cells would likely improve IVF success. Aneuploidy in human embryos leads to altered metabolism. The co-factors utilized in cellular metabolism are autofluorescent and can be used to predict the metabolic state of cells. Here we used hyperspectral imaging to noninvasively assess intracellular fluorophores and thus metabolism. In this study, we utilized a powerful model of embryo aneuploidy where we generate mouse embryos with differing ratios of euploid:aneuploid cells. We also used primary human fibroblast cells with known aneuploidies to make comparison with euploid cells. Hyperspectral imaging of 1:3 chimeric embryos showed a distinct spectral profile compare to the control/normal embryos. The abundance of FAD in the inner cell mass (cells that form the fetus) of euploid and aneuploid blastocysts was strikingly different. For human cell lines, we were able to clearly distinguish between euploid and aneuploid with different karyotypes. These data show hyperspectral imaging is able to distinguish cells based on their ploidy status making it a promising tool in assessing embryo mosaicism.

Citation Download Citation

Tiffany C. Y. Tan, Carl Campugan, Saabah B. Mahbub, Jared M. Campbell, Abbas Habibalahi, Sanam Mustafa, Ewa M. Goldys, Jeremy G. Thompson, and Kylie R. Dunning "Hyperspectral imaging of the early embryo: can it detect chromosome abnormalities and predict IVF success?", Proc. SPIE 11202, Biophotonics Australasia 2019, 112020M (30 December 2019); https://doi.org/10.1117/12.2541282

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available